The Scientist

» cancer, disease/medicine and immunology

Most Recent

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

The Centers for Medicare and Medicaid Services propose covering the test with Medicare. 

0 Comments

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

0 Comments

When peripheral nerves are severed, Schwann cells at the injury site begin to proliferate and exhibit stem cell-like gene expression patterns.

0 Comments

image: The Rising Research Profile of 23andMe

The Rising Research Profile of 23andMe

By | December 1, 2017

An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

0 Comments

The approval of the Roundup ingredient follows an extensive debate amidst conflicting evidence over the health effects of the world’s most popular weed killer. 

0 Comments

Medical organizations endorse the “Undetectable = Untransmissible” campaign, which aims to raise awareness of scientific evidence showing that virally suppressed people living with HIV cannot infect others.

0 Comments

image: Prions Found in Skin of Creutzfeldt-Jakob Patients

Prions Found in Skin of Creutzfeldt-Jakob Patients

By | November 24, 2017

Infectious protein aggregates from the skin of human patients can cause disease in mice.

0 Comments

image: Different Alcoholic Drinks Tied to Different Moods

Different Alcoholic Drinks Tied to Different Moods

By | November 22, 2017

An online survey finds that people report feeling most relaxed with a glass of red wine or beer, and most aggressive when drinking spirits.

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. The Rising Research Profile of 23andMe
    News Analysis The Rising Research Profile of 23andMe

    An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

FreeShip